Evertis has selected Honeywell's Aclar film for its Evercare pharmaceutical brand, aiming to improve packaging solutions ...

Explore how India's 20-year product patent regime transformed its pharma industry from generics to innovation, the economic ...

From 2020 to 2024, universities contributed patents underpinning 50% of FDA-approved drugs. 87% of those academic ...

Amgen faces major revenue risk from upcoming patent cliffs but has promising pipeline drugs to offset losses. Learn why AMGN ...

TWN calls for urgent need of stronger scrutiny in granting patents to avoid evergreening: Our Bureau, New Delhi Tuesday, June 3, 2025, 08:00 Hrs [IST] Third World Network (TWN), a ...

Congress added — and then abruptly dropped — a section of a proposed spending bill aimed at limiting the number of patents pharmaceutical manufacturers could assert in ...

India’s offer comes in the backdrop of the US administration’s stated desire to sharply reduce local drug prices, and gains ...

India has offered to supply complex generics at just 20–25 percent of the branded drug prices for the first three years after ...

Pharmaceutical companies are obligated to follow regulations and are responsible for continuously monitoring the safety of their products and updating safety labels as new information becomes ...

"Indian pharma companies have invested in biologics and biosimilars, giving them the technical capability to produce insulin at scale," said Rajeev Juneja, managing director and vice chairman of ...

2 M&A plays a key role in bringing highly lucrative medications to market, as large pharmaceutical companies often look to invest in young biotechnology companies for their innovative products.